Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danièle Debruyne

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Substance Abuse and Rehabilitation|November 7, 2015
Emerging drugs of abuse: current perspectives on synthetic cannabinoidsDanièle Debruyne, Reynald Le Boisselier
Journal of Neuroscience Methods|January 21, 2006
Competitive displacement binding assay on rat brain sections and using a beta-imager: application to mu-opioid ligandsGéraldine Poisnel, Thomas Quentin, Louisa Barré, et al.
Therapie|July 10, 2016
[Not Available]Danièle Bentué-Ferrer, Olivier Tribut, Marie-Clémence Verdier, et al.
Therapie|August 12, 2010
[Therapeutic drug monitoring of clobazam]Danièle Bentué-Ferrer, Olivier Tribut, Marie-Clémence Verdier, et al.
Journal of Pharmacological Sciences|May 16, 2009
Comparison of five benzodiazepine-receptor agonists on buprenorphine-induced mu-opioid receptor regulationGéraldine Poisnel, Martine Dhilly, Reynald Le Boisselier, et al.
Therapie|April 11, 2015
New synthetic drugs in addictovigilanceFrançois Chavant, Alexandra Boucher, Reynald Le Boisselier, et al.
Substance Abuse and Rehabilitation|June 27, 2014
Emerging drugs of abuse: current perspectives on substituted cathinonesMagalie Paillet-Loilier, Alexandre Cesbron, Reynald Le Boisselier, et al.
Drug and Alcohol Dependence|May 25, 2006
Interactions of buprenorphine and dipotassium clorazepate on anxiety and memory functions in the mouseVéronique Lelong-Boulouard, Thomas Quentin, Fabien Moreaux, et al.
Brain Research|July 19, 2005
Acute and chronic administration of clorazepate modifies the cell surface regulation of mu opioid receptors induced by buprenorphine in specific regions of the rat brainDanièle Debruyne, Thomas Quentin, Géraldine Poisnel, et al.
Therapie|August 12, 2010
[Therapeutic drug monitoring of clonazepam]Danièle Debruyne, Magalie Pailliet-Loilier, Véronique Lelong-Boulouard, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Substance Abuse and Rehabilitation|November 7, 2015
Emerging drugs of abuse: current perspectives on synthetic cannabinoidsDanièle Debruyne, Reynald Le Boisselier
Journal of Neuroscience Methods|January 21, 2006
Competitive displacement binding assay on rat brain sections and using a beta-imager: application to mu-opioid ligandsGéraldine Poisnel, Thomas Quentin, Louisa Barré, et al.
Therapie|July 10, 2016
[Not Available]Danièle Bentué-Ferrer, Olivier Tribut, Marie-Clémence Verdier, et al.
Therapie|August 12, 2010
[Therapeutic drug monitoring of clobazam]Danièle Bentué-Ferrer, Olivier Tribut, Marie-Clémence Verdier, et al.
Journal of Pharmacological Sciences|May 16, 2009
Comparison of five benzodiazepine-receptor agonists on buprenorphine-induced mu-opioid receptor regulationGéraldine Poisnel, Martine Dhilly, Reynald Le Boisselier, et al.
Therapie|April 11, 2015
New synthetic drugs in addictovigilanceFrançois Chavant, Alexandra Boucher, Reynald Le Boisselier, et al.
Substance Abuse and Rehabilitation|June 27, 2014
Emerging drugs of abuse: current perspectives on substituted cathinonesMagalie Paillet-Loilier, Alexandre Cesbron, Reynald Le Boisselier, et al.
Drug and Alcohol Dependence|May 25, 2006
Interactions of buprenorphine and dipotassium clorazepate on anxiety and memory functions in the mouseVéronique Lelong-Boulouard, Thomas Quentin, Fabien Moreaux, et al.
Brain Research|July 19, 2005
Acute and chronic administration of clorazepate modifies the cell surface regulation of mu opioid receptors induced by buprenorphine in specific regions of the rat brainDanièle Debruyne, Thomas Quentin, Géraldine Poisnel, et al.
Therapie|August 12, 2010
[Therapeutic drug monitoring of clonazepam]Danièle Debruyne, Magalie Pailliet-Loilier, Véronique Lelong-Boulouard, et al.
Pageof 4